Lawrence Serfaty

17.6k citations
161 papers · 7.9k · 4 hit papers · h-index 43

Impact in

  • Hepatology top 0.1%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Liver Diseases and Immunity
  • Epidemiology top 0.2%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 79
    • Liver Disease and Transplantation 17
    • Liver Diseases and Immunity 9
    • Liver Disease Diagnosis and Treatment 87
    • Hepatitis B Virus Studies 25

Lawrence Serfaty

156 papers receiving 7.7k citations

Lawrence Serfaty's Hit Papers

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial 2008 · 505 citations
5050+9+18Years since publication100200300400500

Peers

Lawrence Serfaty
Comparison fields: 5 of 107
  • Hepatology 4.3k
  • Epidemiology 4.7k
  • Endocrinology, Diabetes and Metabolism 853
  • Pathology and Forensic Medicine 835
  • Gastroenterology 139
Replace Thierry Poynard with:
Thierry Poynard France
Salvatore Petta Italy
Christophe Moreno Belgium
Aleksander Krag Denmark
Rolf Hultcrantz Sweden
Hari S. Conjeevaram United States
Jérôme Boursier France
Ashwani K. Singal United States
Andreas Geier Germany
Yuichiro Eguchi Japan
Lawrence Serfaty relative to Thierry Poynard France Thierry Poynard's profile →
Citations per field
00.5×1.5×
Thierry Poynard · 1×
Citations per year

Countries citing papers authored by Lawrence Serfaty

Since Specialization
Citations

This map shows the geographic impact of Lawrence Serfaty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Serfaty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Serfaty more than expected).

Fields of papers citing papers by Lawrence Serfaty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Serfaty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Serfaty. The network helps show where Lawrence Serfaty may publish in the future.

Co-authors

The 25 scholars most cited alongside Lawrence Serfaty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lawrence Serfaty Line = papers co-authored together Lawrence Serfaty links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved survival after variceal bleeding in patients with cirrhosis over the past two decades
Hit paper breakdown →
2004558
2
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
Hit paper breakdown →
2008505
3
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy
Hit paper breakdown →
1998499
4
The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids
Hit paper breakdown →
2007485
5 1998323
6 2012317
7 2010259
8 2001245
9 1996204
10 2005185
11 2004149
12 2003138
13 2005132
14 2016125
15 2008125
16 2010114
17 2013112
18 2009111
19 1995104
20 1997102

About Lawrence Serfaty

Lawrence Serfaty is a scholar working on Hepatology, Epidemiology, Surgery, Rheumatology and Molecular Biology, having authored 161 papers that have together received 7.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (87 papers), Hepatitis C virus research (79 papers), Hepatitis B Virus Studies (25 papers), Liver Disease and Transplantation (17 papers), Systemic Lupus Erythematosus Research (10 papers), Liver Diseases and Immunity (9 papers), Diet, Metabolism, and Disease (8 papers) and Alcohol Consumption and Health Effects (8 papers). The work is most often cited by research in Hepatology (4.3k citations), Epidemiology (4.7k citations), Endocrinology, Diabetes and Metabolism (853 citations), Pathology and Forensic Medicine (835 citations) and Gastroenterology (139 citations). Lawrence Serfaty has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Olivier Chazouillères, Raoul Poupon, Dominique Wendum, Olivier Rosmorduc, Nicolas Carbonell, Maud Lemoine, Raoul Poupon, R. Poupon, Arnaud Pauwels and O Fourdan. Their work appears in journals such as Journal of Hepatology, Hepatology, Liver International, Gastroenterology and Journal of Viral Hepatitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact